95 related articles for article (PubMed ID: 28501461)
1. Spliceosome-associated factor CTNNBL1 promotes proliferation and invasion in ovarian cancer.
Li Y; Guo H; Jin C; Qiu C; Gao M; Zhang L; Liu Z; Kong B
Exp Cell Res; 2017 Aug; 357(1):124-134. PubMed ID: 28501461
[TBL] [Abstract][Full Text] [Related]
2. Deficiency in spliceosome-associated factor CTNNBL1 does not affect ongoing cell cycling but delays exit from quiescence and results in embryonic lethality in mice.
Chandra A; van Maldegem F; Andrews S; Neuberger MS; Rada C
Cell Cycle; 2013 Mar; 12(5):732-42. PubMed ID: 23343763
[TBL] [Abstract][Full Text] [Related]
3. CTNNBL1 facilitates the association of CWC15 with CDC5L and is required to maintain the abundance of the Prp19 spliceosomal complex.
van Maldegem F; Maslen S; Johnson CM; Chandra A; Ganesh K; Skehel M; Rada C
Nucleic Acids Res; 2015 Aug; 43(14):7058-69. PubMed ID: 26130721
[TBL] [Abstract][Full Text] [Related]
4. Interaction between antibody-diversification enzyme AID and spliceosome-associated factor CTNNBL1.
Conticello SG; Ganesh K; Xue K; Lu M; Rada C; Neuberger MS
Mol Cell; 2008 Aug; 31(4):474-484. PubMed ID: 18722174
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of EHF inhibited the proliferation, invasion and tumorigenesis of ovarian cancer cells.
Cheng Z; Guo J; Chen L; Luo N; Yang W; Qu X
Mol Carcinog; 2016 Jun; 55(6):1048-59. PubMed ID: 26258986
[TBL] [Abstract][Full Text] [Related]
6. Expression of Par3 polarity protein correlates with poor prognosis in ovarian cancer.
Nakamura H; Nagasaka K; Kawana K; Taguchi A; Uehara Y; Yoshida M; Sato M; Nishida H; Fujimoto A; Inoue T; Adachi K; Nagamatsu T; Arimoto T; Oda K; Osuga Y; Fujii T
BMC Cancer; 2016 Nov; 16(1):897. PubMed ID: 27855669
[TBL] [Abstract][Full Text] [Related]
7. Splicing factor USP39 promotes ovarian cancer malignancy through maintaining efficient splicing of oncogenic HMGA2.
Wang S; Wang Z; Li J; Qin J; Song J; Li Y; Zhao L; Zhang X; Guo H; Shao C; Kong B; Liu Z
Cell Death Dis; 2021 Mar; 12(4):294. PubMed ID: 33731694
[TBL] [Abstract][Full Text] [Related]
8. Aberrant over-expression of COX-1 intersects multiple pro-tumorigenic pathways in high-grade serous ovarian cancer.
Wilson AJ; Fadare O; Beeghly-Fadiel A; Son DS; Liu Q; Zhao S; Saskowski J; Uddin MJ; Daniel C; Crews B; Lehmann BD; Pietenpol JA; Crispens MA; Marnett LJ; Khabele D
Oncotarget; 2015 Aug; 6(25):21353-68. PubMed ID: 25972361
[TBL] [Abstract][Full Text] [Related]
9. Activation-induced cytidine deaminase (AID) is localized to subnuclear domains enriched in splicing factors.
Hu Y; Ericsson I; Doseth B; Liabakk NB; Krokan HE; Kavli B
Exp Cell Res; 2014 Mar; 322(1):178-92. PubMed ID: 24434356
[TBL] [Abstract][Full Text] [Related]
10. Highly expressed NRSN2 is related to malignant phenotype in ovarian cancer.
Tang W; Ren A; Xiao H; Sun H; Li B
Biomed Pharmacother; 2017 Jan; 85():248-255. PubMed ID: 27908706
[TBL] [Abstract][Full Text] [Related]
11. ELF3 is a negative regulator of epithelial-mesenchymal transition in ovarian cancer cells.
Yeung TL; Leung CS; Wong KK; Gutierrez-Hartmann A; Kwong J; Gershenson DM; Mok SC
Oncotarget; 2017 Mar; 8(10):16951-16963. PubMed ID: 28199976
[TBL] [Abstract][Full Text] [Related]
12. EVI1 overexpression promotes ovarian cancer progression by regulating estrogen signaling.
Wang Z; Li Y; Wang N; Li P; Kong B; Liu Z
Mol Cell Endocrinol; 2021 Aug; 534():111367. PubMed ID: 34146645
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast growth factor 19 is correlated with an unfavorable prognosis and promotes progression by activating fibroblast growth factor receptor 4 in advanced-stage serous ovarian cancer.
Hu L; Cong L
Oncol Rep; 2015 Nov; 34(5):2683-91. PubMed ID: 26323668
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of HE4 (human epididymis protein 4) enhances proliferation, invasion and metastasis of ovarian cancer.
Zhu L; Zhuang H; Wang H; Tan M; Schwab CL; Deng L; Gao J; Hao Y; Li X; Gao S; Liu J; Lin B
Oncotarget; 2016 Jan; 7(1):729-44. PubMed ID: 26575020
[TBL] [Abstract][Full Text] [Related]
15. The variant hepatocyte nuclear factor 1 activates the P1 promoter of the human alpha-folate receptor gene in ovarian carcinoma.
Tomassetti A; Mangiarotti F; Mazzi M; Sforzini S; Miotti S; Galmozzi E; Elwood PC; Canevari S
Cancer Res; 2003 Feb; 63(3):696-704. PubMed ID: 12566316
[TBL] [Abstract][Full Text] [Related]
16. Cancer-associated fibroblasts secrete FGF-1 to promote ovarian proliferation, migration, and invasion through the activation of FGF-1/FGFR4 signaling.
Sun Y; Fan X; Zhang Q; Shi X; Xu G; Zou C
Tumour Biol; 2017 Jul; 39(7):1010428317712592. PubMed ID: 28718374
[TBL] [Abstract][Full Text] [Related]
17. TMPRSS3 modulates ovarian cancer cell proliferation, invasion and metastasis.
Zhang D; Qiu S; Wang Q; Zheng J
Oncol Rep; 2016 Jan; 35(1):81-8. PubMed ID: 26531004
[TBL] [Abstract][Full Text] [Related]
18. Small angle X-ray scattering studies of CTNNBL1 dimerization and CTNNBL1/CDC5L complex.
Ahn JW; Jin KS; Son HF; Chang JH; Kim KJ
Sci Rep; 2015 Sep; 5():14251. PubMed ID: 26381213
[TBL] [Abstract][Full Text] [Related]
19. NFATc1 regulates cell proliferation, migration, and invasion of ovarian cancer SKOV3 cells in vitro and in vivo.
Li L; Duan Z; Yu J; Dang HX
Oncol Rep; 2016 Aug; 36(2):918-28. PubMed ID: 27350254
[TBL] [Abstract][Full Text] [Related]
20. Expression of Interactive Genes Associated with Apoptosis and Their Prognostic Value for Ovarian Serous Adenocarcinoma.
Shin K; Kim KH; Yoon MS; Suh DS; Lee JY; Kim A; Eo W
Adv Clin Exp Med; 2016; 25(3):513-21. PubMed ID: 27629740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
